Utah Retirement Systems’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.32M Hold
64,262
0.02% 519
2025
Q1
$2M Sell
64,262
-338
-0.5% -$10.5K 0.02% 548
2024
Q4
$1.65M Hold
64,600
0.02% 605
2024
Q3
$1.83M Hold
64,600
0.02% 586
2024
Q2
$1.7M Buy
64,600
+500
+0.8% +$13.2K 0.02% 584
2024
Q1
$1.95M Sell
64,100
-100
-0.2% -$3.04K 0.02% 571
2023
Q4
$1.8M Buy
64,200
+400
+0.6% +$11.2K 0.02% 575
2023
Q3
$1.73M Buy
63,800
+200
+0.3% +$5.43K 0.02% 561
2023
Q2
$1.96M Sell
63,600
-2,700
-4% -$83K 0.03% 535
2023
Q1
$2.39M Hold
66,300
0.03% 474
2022
Q4
$2.62M Buy
66,300
+600
+0.9% +$23.7K 0.04% 411
2022
Q3
$2.64M Buy
65,700
+200
+0.3% +$8.03K 0.04% 395
2022
Q2
$2.75M Buy
65,500
+7,500
+13% +$315K 0.04% 398
2022
Q1
$2.26M Sell
58,000
-1,000
-2% -$38.9K 0.03% 509
2021
Q4
$2.35M Buy
59,000
+200
+0.3% +$7.97K 0.03% 520
2021
Q3
$2.13M Sell
58,800
-2,800
-5% -$101K 0.03% 543
2021
Q2
$2.53M Buy
61,600
+200
+0.3% +$8.2K 0.03% 509
2021
Q1
$2.68M Buy
61,400
+40,300
+191% +$1.76M 0.04% 467
2020
Q4
$1.06M Buy
+21,100
New +$1.06M 0.02% 730